Farvardin Professorship Fund Reaches $500K

Farvardin Professorship Fund Reaches $500K

Farvardin Professorship Fund Reaches $500K

Nariman Farvardin, former Clark School dean and current UM provost. (Photo by Bill Geiger)
Nariman Farvardin, former Clark School dean and current UM provost. (Photo by Bill Geiger)

A professorship fund established in honor of Nariman Farvardin, former Clark School dean and current UM provost, has reached $500,000.

The professorship will be used to provide support to recruit or retain a professor of engineering.

A gift of $140,000 by Jeong H. Kim helped the fund to reach the $500,000 milestone. Kim is a professor of practice in reliability engineering at the Clark School and the man for whom the Kim Building is named.

Kim's gift is one of four leadership gifts toward the fund. The other three have come from Clark School Board of Visitors Chair Tom Scholl, Aris Mardirossian (B.S. '74 and M.S. '75, mechanical engineering) and Clark School benefactor A. James Clark.

The fund has also been supported by numerous gifts by Clark School faculty, staff, alumni and friends.

"We are grateful to all donors whose generosity led to the endowment of the Nariman Farvardin Professorship," said Interim Dean Herbert Rabin. "A named professorship is an appropriate testament to Dr. Farvardin's leadership of the Clark School of Engineering from 2000 to 2007."

To learn more about the Great Expectations campaign and how you can make a difference in the Clark School's progress, please contact Steve Beeland.

September 26, 2007


Prev   Next

Current Headlines

Shellfish Waste Engineered to Preserve Produce for Healthier, Longer Shelf Life

An Insider’s Look at UMD’s Research on Eco-Friendly HVAC&R

Maryland Engineers Recognized with UMD Faculty Honors

Carlos A. Ríos Ocampo To Attend NAE’s Frontiers of Engineering Symposium

Farewell to Postdoc Researcher Lei Gao

Two UMD Students Win Spots in SAMPE University Research Symposium

Mirdamadi Wins First Prize at Translational Research Competition

New features on ingestible capsule will deliver targeted drugs to better treat IBD, Crohn’s disease

News Resources

Return to Newsroom

Search News

Archived News

Events Resources

Events Calendar